Marc de Garidel, Chief Executive Officer at CinCor Pharma, Inc. (CINC), bought 12,500 shares at $16.00 ($200K) on 2022-01-11, disclosed to the SEC on 2022-01-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.